Annovis Bio, Inc.
101 Lindenwood Drive, Suite 225
Malvern, PA 19355
Tel: (484) 875-3192
February 9, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Daniel Crawford
Re: | Annovis Bio, Inc. |
Registration Statement on Form S-3
File No. 333-276814
Dear Mr. Crawford:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the registrant Annovis Bio, Inc.. hereby requests acceleration of effectiveness of the above-referenced Registration Statement so that it will become effective at 4:15 p.m. ET on Monday, February 12, 2024, or as soon as practicable thereafter.
Very truly yours,
ANNOVIS BIO, INC. | ||
By: | /s/ Henry Hagopian III | |
Name: | Henry Hagopian III | |
Title: | Chief Financial Officer |